Tania Cernuschi

Hello, please check out recent feedback from the Immunization and vaccines related implementation research advisory committee (IVIR-AC) on the newly-launched WHO Market Information for Access Initiative (MI4A) and methodology:

"The initiative is providing a valuable public good that could shape markets and ultimately save lives if greater transparency and less information asymmetry generally lead to more efficient markets."

View the full IVIR-AC recommendations in the current edition of WHO's Weekly Epidemiological Record:

https://apps.who.int/iris/bitstream/handle/10665/312312/WER9419.pdf

MI4A provides a unique global perspective on vaccine markets, covering all countries and vaccines with objectives to:

• Enhance the understanding of global vaccine demand, supply and pricing dynamics and identifying affordability and shortage risks;
• Convene all relevant global health partners to contribute to the development of policies, strategies, and guidance to address the identified risks;
• Strengthen national and regional capacity for improved access to vaccines supply.

For more information on MI4A please see:

www.who.int/immunization/MI4A

Tania